Why TransEnterix Stock Is Soaring Today
Shares of the robotic-surgery company TransEnterix (NYSEMKT: TRXC) rose by as much as 69% today in early morning trading. This small-cap healthcare stock has now appreciated by over 200% since the U.S. Food and Drug Administration, or FDA, approved its Senhance Surgical Robotic System just last Friday.
Image source: Getty Images.
TransEnterix's Senhance Surgical Robotic System is designed to compete directly with Intuitive Surgical's (NASDAQ: ISRG) market-leading da Vinci system. Although there's no guarantee of success, the commercial opportunity presented by the rapidly growing robotic surgery market is absolutely immense, to put it mildly.
Source: Fool.com
Johnson & Johnson Stock
The stock is one of the favorites of our community with 56 Buy predictions and 2 Sell predictions.
With a target price of 163 € there is a slightly positive potential of 18.56% for Johnson & Johnson compared to the current price of 137.48 €.